Explaining symptom severity, distress and disability in chronic pain: The role of mental defeat

解释慢性疼痛的症状严重程度、痛苦和残疾:精神挫败的作用

基本信息

  • 批准号:
    MR/S026185/1
  • 负责人:
  • 金额:
    $ 72.89万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Research Grant
  • 财政年份:
    2019
  • 资助国家:
    英国
  • 起止时间:
    2019 至 无数据
  • 项目状态:
    已结题

项目摘要

Chronic pain is a global health problem that affects around 8 million people in the UK. Although it cannot be seen, its impact on people's day-to-day activities, physical health and psychological wellbeing is highly visible and far-reaching. Research has shown that chronic pain is the reason for >4 million GP appointments each year and that the presence of chronic pain raises the risk of depression and suicide by two to three times. Most cases of chronic pain do not have a specific known cause, and hence are impossible to cure. Helping people to live well despite chronic pain is therefore the ultimate goal of pain management programmes, although the effect of these psychological interventions has been frustratingly modest. Identifying the psychological factor that explains the progression of symptom severity and predicts the development of distress or breakdown of self-management will offer important clues to advancing these treatments. Existing psychological interventions for chronic pain typically focus on symptom management, overlooking the impact of chronic pain on the person's deeper sense of self and identity. Work by our group has discovered that people who are most distressed and disabled by chronic pain tend to have a strong sense of mental defeat, such that they feel that they have lost an important battle with chronic pain. Such defeated state of mind is characterised by a perceived loss of autonomy, social rank and human integrity. The concept of mental defeat is relevant to the explanation of depression, post-traumatic stress disorder and suicide. It can be measured and we have initial evidence to suggest that mental defeat can better explain pain interference and the seeking of specialist pain treatment, compared to psychological processes (e.g., pain catastrophising) targeted by current treatments. The proposed research will provide an in-depth investigation of the role of mental defeat in the development of symptoms, distress and disability associated with chronic pain. The research has three methodologically complementary components. Specifically, we will carry out a tightly-controlled experiment in the laboratory, a questionnaire study and an experience sampling study in the participant's natural living environment over the course of a year. Together, these will generate the first experimental and longitudinal evidence necessary to: Aim 1 - evaluate how pain responses are altered when the sense of mental defeat is activated, Aim 2 - determine the extent to which mental defeat is associated with physical, psychological and social outcomes in 6 and 12 months, and Aim 3 - delineate the potential day-to-day processes, such as attention, mood, stress, physical and social activity, sleep and use of medication, through which mental defeat aggravates symptoms and translates into a source of distress and disability. The proposed research aims to inform treatment development and will be carried out with people living with chronic pain to maximise its clinical relevance. Earlier research on mental defeat in chronic pain was limited by their qualitative and correlational nature due to understandable ethical concerns and a lack of viable experimental protocol. The proposed research will apply a thought manipulation technique successfully developed by our group to temporarily activate a pain-related sense of mental defeat without causing undue distress to the participants. It will also capitalise on data monitoring and analytic techniques the group is known for, to evaluate the temporal relationship between mental defeat and outcomes of interest in the real world from the patient's perspective. Findings of the research will have a bearing on future psychological theories of chronic pain and open up exciting avenues for a broader understanding of chronic pain and its closely aligned ailments, including depression, post-traumatic stress and suicide.
慢性疼痛是一个全球性的健康问题,影响着英国约800万人。虽然看不见,但它对人们日常活动、身体健康和心理健康的影响是非常明显和深远的。研究表明,慢性疼痛是每年400万家庭医生就诊的原因,慢性疼痛的存在使抑郁和自杀的风险增加了两到三倍。大多数慢性疼痛病例没有明确的已知原因,因此不可能治愈。因此,尽管这些心理干预的效果令人沮丧,但帮助人们在慢性疼痛的情况下生活得更好是疼痛管理规划的最终目标。确定解释症状严重程度进展的心理因素,并预测痛苦或自我管理崩溃的发展,将为推进这些治疗提供重要线索。现有的慢性疼痛心理干预通常侧重于症状管理,忽视了慢性疼痛对人的深层自我意识和身份的影响。我们小组的工作发现,那些被慢性疼痛折磨得最痛苦和残疾的人往往有一种强烈的精神挫败感,以至于他们觉得自己输掉了一场与慢性疼痛的重要战斗。这种失败的心理状态的特点是感觉到自主权、社会地位和人格完整性的丧失。心理失败的概念与抑郁症、创伤后应激障碍和自杀的解释有关。它是可以测量的,我们有初步的证据表明,与目前治疗针对的心理过程(例如,疼痛灾难)相比,心理失败可以更好地解释疼痛干扰和寻求专业疼痛治疗。拟议的研究将提供一个深入的调查心理失败的作用,在发展的症状,痛苦和残疾与慢性疼痛相关。这项研究在方法论上有三个互补的组成部分。具体来说,我们将在一年的时间里,在实验室进行严格控制的实验,在参与者的自然生活环境中进行问卷调查研究和经验抽样研究。总之,这些将产生第一个必要的实验和纵向证据,以便:目标1 -评估当精神挫败感被激活时,疼痛反应是如何改变的;目标2 -确定精神挫败在多大程度上与6个月和12个月的身体、心理和社会结果相关;目标3 -描述潜在的日常过程,如注意力、情绪、压力、身体和社会活动、睡眠和药物使用,通过这些过程,精神挫败会加重症状,并转化为痛苦和残疾的来源。拟议的研究旨在为治疗开发提供信息,并将与慢性疼痛患者一起进行,以最大限度地提高其临床相关性。由于可以理解的伦理问题和缺乏可行的实验方案,早期关于慢性疼痛中心理失败的研究受到定性和相关性的限制。本研究将采用我们小组成功开发的思想操纵技术,暂时激活与疼痛相关的精神挫败感,而不会给参与者造成不必要的痛苦。它还将利用该组织闻名的数据监测和分析技术,从患者的角度评估精神失败与现实世界中感兴趣的结果之间的时间关系。这项研究的发现将对未来慢性疼痛的心理学理论产生影响,并为更广泛地了解慢性疼痛及其密切相关的疾病(包括抑郁症、创伤后应激障碍和自杀)开辟令人兴奋的途径。

项目成果

期刊论文数量(9)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
An exploratory investigation into the effects of mental defeat on pain threshold, pain rating, pain anticipation, and mood
  • DOI:
    10.1007/s12144-021-01548-3
  • 发表时间:
    2021-03-10
  • 期刊:
  • 影响因子:
    2.8
  • 作者:
    Collard, Victoria E. J.;Gillett, Jenna L.;Tang, Nicole K. Y.
  • 通讯作者:
    Tang, Nicole K. Y.
Mental Defeat and Suicidality in Chronic Pain: A Prospective Analysis.
慢性疼痛中的精神挫败和自杀:前瞻性分析。
  • DOI:
    10.1016/j.jpain.2023.06.017
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Themelis K
  • 通讯作者:
    Themelis K
Investigating mental defeat in individuals with chronic pain: Protocol for a longitudinal experience sampling study.
  • DOI:
    10.1136/bmjopen-2022-066577
  • 发表时间:
    2023-02-06
  • 期刊:
  • 影响因子:
    2.9
  • 作者:
  • 通讯作者:
Cover Overlapping Pain and Psychiatric Syndromes: Global Perspectives
涵盖重叠疼痛和精神综合症:全球视角
  • DOI:
  • 发表时间:
    2020
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Cheatle, Martin D., Foster, Simmie, Tang, Nicole KY
  • 通讯作者:
    Cheatle, Martin D., Foster, Simmie, Tang, Nicole KY
Cognitive factors and processes in models of insomnia: A systematic review.
失眠模型中的认知因素和过程:系统评价。
  • DOI:
    10.1111/jsr.13923
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    4.4
  • 作者:
    Tang NKY
  • 通讯作者:
    Tang NKY
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Nicole Tang其他文献

Palliative Care Needs in Patients with Heart Failure Presenting to the Emergency Department: A Patient-Centered Evaluation of Health Status and Quality of Life Approach (S769)
  • DOI:
    10.1016/j.jpainsymman.2016.12.280
  • 发表时间:
    2017-02-01
  • 期刊:
  • 影响因子:
  • 作者:
    Carrie Vuong;Rebecca Wright;Nicole Tang;Corita Grudzen
  • 通讯作者:
    Corita Grudzen
Su1528 RISING PREVALENCE AND LONGITUDINAL EFFECTS ON MORTALITY BASED ON SPECTRUM OF ALCOHOL INTAKE IN STEATOTIC LIVER DISEASE (MASLD, METALD AND ALD). A US POPULATION STUDY
  • DOI:
    10.1016/s0016-5085(24)04197-0
  • 发表时间:
    2024-05-18
  • 期刊:
  • 影响因子:
  • 作者:
    Christen Ong;Nicole Tang;Shyna Gunalan;Jia Hong Koh;Mark Muthiah;Karn Wijarnpreecha;Daniel Huang;Nicholas L. Syn;Mazen Noureddin
  • 通讯作者:
    Mazen Noureddin

Nicole Tang的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似海外基金

Microbiome targeted oral butyrate therapy in Gulf War multisymptom illness
微生物组靶向口服丁酸盐治疗海湾战争多症状疾病
  • 批准号:
    10367805
  • 财政年份:
    2023
  • 资助金额:
    $ 72.89万
  • 项目类别:
The impact of hormonal modulation on systemic inflammation and central sensitization
激素调节对全身炎症和中枢敏化的影响
  • 批准号:
    10584701
  • 财政年份:
    2023
  • 资助金额:
    $ 72.89万
  • 项目类别:
Understanding and targeting fibroblast activation in influenza-triggered lung inflammation and post-viral disease
了解和靶向流感引发的肺部炎症和病毒后疾病中的成纤维细胞激活
  • 批准号:
    10717809
  • 财政年份:
    2023
  • 资助金额:
    $ 72.89万
  • 项目类别:
Achieving Sustained Control of Inflammation to Prevent Post-Traumatic Osteoarthritis (PTOA)
实现炎症的持续控制以预防创伤后骨关节炎 (PTOA)
  • 批准号:
    10641225
  • 财政年份:
    2023
  • 资助金额:
    $ 72.89万
  • 项目类别:
A Multi-Modal Combination Intervention to Promote Cognitive Function in Older Intensive Care Unit Survivors
促进老年重症监护病房幸存者认知功能的多模式组合干预
  • 批准号:
    10662893
  • 财政年份:
    2023
  • 资助金额:
    $ 72.89万
  • 项目类别:
Morning Light Treatment for Inflammatory Bowel Disease: A Pilot Clinical Trial
晨光治疗炎症性肠病:初步临床试验
  • 批准号:
    10710708
  • 财政年份:
    2023
  • 资助金额:
    $ 72.89万
  • 项目类别:
Effects of deep brain stimulation (DBS) on laryngeal function and associated behaviors in Parkinson Disease
深部脑刺激(DBS)对帕金森病喉功能和相关行为的影响
  • 批准号:
    10735930
  • 财政年份:
    2023
  • 资助金额:
    $ 72.89万
  • 项目类别:
Long-term Neuropsychiatric Sequelae of SARS-CoV-2 Infection in Late Life
晚年 SARS-CoV-2 感染的长期神经精神后遗症
  • 批准号:
    10586560
  • 财政年份:
    2023
  • 资助金额:
    $ 72.89万
  • 项目类别:
Genetic basis for persistence of Borrelia burgdorferi
伯氏疏螺旋体持续存在的遗传基础
  • 批准号:
    10737678
  • 财政年份:
    2023
  • 资助金额:
    $ 72.89万
  • 项目类别:
Risk Stratification for COPD Exacerbations with CT Analysis and Multidimensional Trajectory Subtyping
通过 CT 分析和多维轨迹分型对 COPD 恶化进行风险分层
  • 批准号:
    10658547
  • 财政年份:
    2023
  • 资助金额:
    $ 72.89万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了